Related Experiment Video

Updated: Apr 24, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

778

Potentially Preventable Hospitalizations for Congestive Heart Failure Among Asian Americans and Pacific Islanders in

Tetine Sentell1, Jill Miyamura, Hyeong Jun Ahn

  • 1Office of Public Health Studies, University of Hawai'i at Manoa, 1960 East-West Road, Biomed T102, Honolulu, HI, 96822, USA, tsentell@hawaii.edu.

Journal of Immigrant and Minority Health
|September 11, 2014
PubMed

Insights

Preventable hospitalizations for congestive heart failure (CHF) disproportionately affect Native Hawaiians and Filipinos, often at younger ages. This highlights disparities in healthcare access for these Asian American and Pacific Islander groups.

Area of Science:

  • Public Health
  • Health Disparities
  • Cardiology

Background:

  • Congestive heart failure (CHF) hospitalizations are often preventable with adequate primary care.
  • Certain Asian American and Pacific Islander (AAPI) populations face healthcare access barriers compared to White populations.
  • Preventable CHF hospitalizations within AAPI groups remain understudied.

Purpose of the Study:

  • To investigate and compare potentially preventable congestive heart failure hospitalizations among diverse racial and ethnic groups in Hawai'i.
  • To identify specific AAPI subgroups with higher rates of preventable CHF hospitalizations.
  • To analyze age and gender differences in these hospitalization rates.

Main Methods:

  • Analysis of hospitalization data from Hawai'i between December 2006 and December 2010.
  • Inclusion of Chinese, Japanese, Native Hawaiian, Filipino, and White individuals aged 18 and older (N = 245,435).
  • Multivariable modeling to compare CHF preventable hospitalizations across racial/ethnic groups, stratified by age (<65 vs. 65+) and gender.

Main Results:

  • Native Hawaiians and Filipinos experienced preventable CHF hospitalizations at significantly younger ages compared to other groups (p < 0.001).
  • Adjusted models revealed higher CHF hospitalization rates for Native Hawaiians and Filipinos across all age and gender categories versus Whites.
  • Chinese women aged 65 and older also showed significantly higher CHF hospitalization rates than Whites.

Conclusions:

  • Specific AAPI groups, particularly Native Hawaiians and Filipinos, exhibit high rates of preventable CHF hospitalizations.
  • These groups are hospitalized for CHF at younger ages, indicating potential disparities in primary care access and management.
  • Findings underscore the need for targeted public health interventions to address healthcare inequities in these communities.

More Related Videos

Implantation of Total Artificial Heart in Congenital Heart Disease07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

28.4K
Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis04:05

Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis

Published on: June 30, 2023

3.0K

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
626
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
793
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
957
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
611